Bone metabolism after cinacalcet administration in patients with secondary hyperparathyroidism

Journal of Bone and Mineral Metabolism

Volumn 28, Issue 1, 2010, Pages 49-54

  Yano, Shozo ^a   Suzuki, Keiko ^b   Sumi, Masaaki ^c   Tokumoto, Akihide ^d   Shigeno, Kazushi ^e   Himeno, Yasutoshi ^c   Sugimoto, Toshitsugu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b Otsuka Clinic   (Japan)

^c Himeno Clinic   (Japan)

^d Kamifukuhara Medical Clinic   (Japan)

^e Ooda Himeno Clinic   (Japan)

Author keywords

Bone metabolism; Cinacalcet; Hemodialysis; Hungry bone; Secondary hyperparathyroidism

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM; CINACALCET; PARATHYROID HORMONE; SEVELAMER; VITAMIN D DERIVATIVE;

ADULT; ARTICLE; BONE METABOLISM; BONE TURNOVER; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG MECHANISM; FEMALE; HEMODIALYSIS; HUMAN; MALE; OBSERVATIONAL STUDY; OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE RELEASE; PARESTHESIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECONDARY HYPERPARATHYROIDISM;

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; BONE REGENERATION; BONE REMODELING; BONE RESORPTION; CALCIUM; DRUG ADMINISTRATION SCHEDULE; FEMALE; HORMONE ANTAGONISTS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; ISOENZYMES; MALE; MIDDLE AGED; NAPHTHALENES; PARATHYROID HORMONE; PHOSPHORUS; RENAL DIALYSIS; TIME FACTORS;

EID: 76949089749     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-009-0102-6     Document Type: Article

References (34)

1. GA Block KJ Martin AL de Francisco SA Turner MM Avram MG Suranyi G Hercz J Cunningham AK Abu-Alfa P Messa DW Coyne F Locatelli RM Cohen P Evenepoel SM Moe A Fournier J Braun LC McCary VJ Zani KA Olson, et al. 2004 Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis N Engl J Med 350 1516 1525 10.1056/NEJMoa031633 1:CAS:528:DC%2BD2cXjtVeqtLY%3D 15071126 (Pubitemid 38477776)
2. JS Lindberg B Culleton G Wong MF Borah RV Clark WB Shapiro SD Roger FE Husserl PS Klassen MD Guo MB Albizem JW Coburn 2005 Cinaclcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study J Am Soc Nephrol 16 800 807 10.1681/ASN.2004060512 1:CAS:528: DC%2BD2MXis12nsr4%3D 15689407 (Pubitemid 41725117)
3. J Cunningham M Danese K Olson P Klassen GM Chertow 2005 Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism Kidney Int 68 1793 1800 10.1111/j.1523-1755.2005.00596.x 1:CAS:528:DC%2BD2MXhtFequ7vI 16164656 (Pubitemid 43169924)
4. M Fukagawa S Yumita T Akizawa E Uchida Y Tsukamoto M Iwasaki S Koshikawa KRN1493 study group 2008 Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients Nephrol Dial Transplant 23 328 335 10.1093/ndt/gfm534 1:CAS:528:DC%2BD1cXmsFSnsQ%3D%3D 17717030 (Pubitemid 351767363)
5. C Henley M Colloton RC Cattley E Shatzen DA Towler D Lacey D Martin 2005 1, 25-Dihydroxyvitamin D3 but not cincalcet HCl treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism Nephrol Dial Transplant 20 1370 1377 10.1093/ndt/gfh834 1:CAS:528:DC%2BD2MXpt1Cjs74%3D 15855208 (Pubitemid 41430610)
6. WG Goodman J Goldin BD Kuizon C Yoon B Gales D Sider Y Wang J Chung A Emerick L Greaser RM Elashoff IB Salusky 2000 Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis N Engl J Med 342 1478 1483 10.1056/NEJM200005183422003 1:STN:280:DC%2BD3c3ls1OjtA%3D%3D 10816185 (Pubitemid 30318271)
7. J Blacher AP Guerin B Pannier SJ Marchais GM London 2001 Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease Hypertension 38 938 942 10.1161/hy1001.096358 1:CAS:528: DC%2BD3MXotVGlsr4%3D 11641313
8. GA Block TE Hulbert-Shearon NW Levin FK Port 1998 Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study Am J Kidney Dis 31 607 617 10.1053/ajkd.1998.v31.pm9531176 1:STN:280:DyaK1c7ovFKlsw%3D%3D 9531176
9. SK Ganesh AG Stack NW Levin T Hulbert-Shearon FK Port 2001 Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients J Am Soc Nephrol 12 2131 2138 1:CAS:528:DC%2BD3MXnsFWiurk%3D 11562412
10. S Yano T Sugimoto T Tsukamoto T Yamaguchi T Hattori KI Sekita H Kaji S Hattori A Kobayashi K Chihara 2003 Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain Horm Metab Res 35 259 264 10.1055/s-2003-39483 1:CAS:528:DC%2BD3sXkslais7s%3D 12778370 (Pubitemid 36754203)
11. K Yokoyama 2008 The calcium-phosphorus in guidelines for CKD-MBD Kidney Int 74 245 10.1038/ki.2008.175 18591947 (Pubitemid 351915091)
12. S Yamada M Inaba M Kurajoh K Shidara Y Imanishi E Ishimura Y Nishizawa 2008 Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction Clin Endocrinol 69 189 196 10.1111/j.1365-2265.2008.03187.x 1:CAS:528:DC%2BD1cXhtVarsL7M (Pubitemid 352009021)
13. P Chu TY Chao YF Lin AJ Janckila LT Yam 2003 Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis Am J Kidney Dis 41 1052 1059 10.1016/S0272-6386(03)00203-8 1:CAS:528:DC%2BD3sXktVOqsLg%3D 12722040 (Pubitemid 36532140)
14. T Ohashi Y Igarashi Y Mochizuki T Miura N Inaba K Katayama T Tomonaga F Nomura 2007 Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b Clin Chim Acta 376 205 212 10.1016/j.cca.2006.08.021 1:CAS:528:DC%2BD28XhtlaltbbL 17045980 (Pubitemid 44889255)
15. National Kidney Foundation 2003 K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease Am J Kidney Dis 42 S1 S201
16. T Shigematsu T Akizawa E Uchida Y Tsukamoto M Iwasaki S Koshikawa 2008 Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism Am J Nephrol 29 230 236 10.1159/000156717 18797166
17. EF Nemeth ME Steffey LG Hammerland BC Hung BC Van Wagenen EG DelMar MF Balandrin 1998 Calcimimetics with potent and selective activity on the parathyroid calcium receptor Proc Natl Acad Sci USA 95 4040 4045 10.1073/pnas.95.7.4040 1:CAS:528:DyaK1cXitlKisrk%3D 9520489 (Pubitemid 28173250)
18. EM Brown RJ MacLeod 2001 Extracellular calcium sensing and extracellular calcium signaling Physiol Rev 81 239 297 1:CAS:528:DC%2BD3MXitV2ktLo%3D 11152759
19. Yano S, Brown EM (2005) Calcium-sensing receptor. In: Naveh-Many T (ed) Molecular biology of the parathyroid. Landes Bioscience/Eurekah.com and Kluwer Academic/Plenum, New York, pp 44-56
20. SJ Silverberg HG Bone III TB Marriott FG Locker S Thys-Jacobs G Dziem S Kaatz EL Sanguinetti JP Bilezikian 1997 Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism N Engl J Med 337 1506 1510 10.1056/NEJM199711203372104 1:CAS:528:DyaK2sXns1yhs7Y%3D 9366582 (Pubitemid 27495776)
21. T Yamaguchi 2008 The calcium-sensing receptor in bone J Bone Miner Metab 26 301 311 10.1007/s00774-008-0843-7 1:CAS:528:DC%2BD1cXotFans7w%3D 18600395 (Pubitemid 351950702)
22. N Chattopadhyay S Yano J Tfelt-Hansen P Rooney D Kanuparthi S Bandyopadhyay X Ren E Terwilliger EM Brown 2004 Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts Endocrinology 145 3451 3462 10.1210/en.2003-1127 1:CAS:528:DC%2BD2cXltFyktrY%3D 15084499 (Pubitemid 38830018)
23. MM Dvorak A Siddiqua DT Ward DH Carter SL Dallas EF Nemeth D Riccardi 2004 Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones Proc Natl Acad Sci USA 101 5140 5145 10.1073/pnas.0306141101 1:CAS:528: DC%2BD2cXjsFCitr0%3D 15051872 (Pubitemid 38469215)
24. M Yamauchi T Yamaguchi H Kaji T Sugimoto K Chihara 2005 Involvement of calcium-sensing receptor in osteoblastic differentiation of of mouse MC3T3-E1 cells Am J Physiol Endocrinol Metab 288 E608 E616 10.1152/ajpendo.00229.2004 1:CAS:528:DC%2BD2MXisVKqsL8%3D 15547142 (Pubitemid 40250557)
25. T Kameda H Mano Y Yamada H Takai N Amizuka M Kobori N Izumi H Kawashima H Ozawa K Ikeda A Kameda Y Hakeda M Kumegawa 1998 Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells Biochem Biophys Res Commun 245 419 422 10.1006/bbrc.1998.8448 1:CAS:528:DyaK1cXivVOqt7w%3D 9571166 (Pubitemid 28418516)
26. M Kanatani T Sugimoto M Kanzawa S Yano K Chihara 1999 High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells Biochem Biophys Res Commun 261 144 148 10.1006/bbrc.1999.0932 1:CAS:528:DyaK1MXktlygur4%3D 10405337 (Pubitemid 29371632)
27. R Mentaverri S Yano N Chattopadhyay L Petit O Kifor S Kamel EF Terwilliger M Brazier EM Brown 2006 The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis FASEB J 20 2562 2564 10.1096/fj.06-6304fje 1:CAS:528:DC%2BD28Xht1ymtbrK 17077282 (Pubitemid 44953781)
28. A Yajima M Inaba Y Ogawa Y Tominaga T Tanizawa T Inou O Otsubo 2007 Significance of time-course changes of serum bone markers after parathyroidectomy in patients with uraemic hyperparathyroidism Nephrol Dial Transplant 22 1645 1657 10.1093/ndt/gfl837 1:CAS:528:DC%2BD2sXot1Sgs7Y%3D 17307749 (Pubitemid 47073764)
29. ES Lazar N Stankus 2007 Cinacalcet-induced hungry bone syndrome Semin Dial 20 83 85 10.1111/j.1525-139X.2007.00248.x 17244128
30. A Yajima T Akizawa Y Tsukamoto S Kurihara A Ito K Study Group 2008 Impact of Cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism Ther Apher Dial 12 S38 S43 10.1111/j.1744-9987.2008.00630.x 1:CAS:528:DC%2BD1MXjsVCntbs%3D 19032526
31. ME Rodriguez Y Almaden S Cañadillas A Canalejo E Siendones I Lopez E Aguilera-Tejero D Martin M Rodriguez 2007 The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands Am J Physiol Renal Physiol 292 F1390 F1395 10.1152/ajprenal.00262.2006 1:CAS:528: DC%2BD2sXlslShtbc%3D 17200160 (Pubitemid 46701865)
32. K Shiizaki S Negi I Hatamura T Sakaguchi F Saji K Kunimoto M Mizobuchi I Imazeki A Ooshima T Akizawa 2005 Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats J Am Soc Nephrol 16 97 108 10.1681/ASN.2004030236 1:CAS:528:DC%2BD2MXotFemtQ%3D%3D 15574509 (Pubitemid 43073161)
33. N Carrillo-López D Alvarez-Hernández I González- Suárez P Román-García JM Valdivielso JL Fernández-Martín JB Cannata-Andía 2008 Simultaneous changes in the calcium-sensing receptor and the vitamin D receptor under the influence of calcium and calcitriol Nephrol Dial Transplant 23 3479 3484 10.1093/ndt/gfn338 18556746
34. GA Block S Zeig J Sugihara GM Chertow EM Chi SA Turner DA Bushinsky TARGET Investigators 2008 Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism Nephrol Dial Transplant 23 2311 2318 10.1093/ndt/gfn026 1:CAS:528:DC%2BD1cXnvFShu78%3D 18310602 (Pubitemid 351957604)